Want to see EBS full AI Analyst Report?
Emergent Biosolutions (EBS) Q2 2024 Earnings Report
EBS Q2 2024 EPS Results
- Actual EPS
- -$2.32
- Consensus EPS
- -$1.14
- Beat/Miss
- Missed by -$1.18
- One Year Ago EPS
- -$1.06
EBS Q2 2024 Revenue Results
- Actual Revenue
- $254.70M
- Expected Revenue
- $190.00M
- Beat/Miss
- Beat by +$64.70M
- YoY Revenue Growth
- -24.62%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- After Close
- Conference Call
- Tuesday, August 6, 2024
EBS Upcoming Earnings
Emergent Biosolutions's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
EBS Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
EBS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.08- | -0.43 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.39-0.36 | 1.06 | -133.96% (-1.42) | |
| Aug 05, 2026 | 2026 (Q2) | -0.090.60 | 0.16 | 275.00% (+0.44) | |
| Apr 30, 2026 | 2026 (Q1) | -0.250.21 | 0.71 | -70.42% (-0.50) | |
| Feb 26, 2026 | 2025 (Q4) | 0.11-0.43 | 0.05 | -960.00% (-0.48) | |
| Oct 29, 2025 | 2025 (Q3) | -0.121.06 | 1.37 | -22.63% (-0.31) | |
| Aug 06, 2025 | 2025 (Q2) | -0.490.16 | -2.32 | 106.90% (+2.48) | |
| May 07, 2025 | 2025 (Q1) | 0.440.71 | 0.59 | 20.34% (+0.12) | |
| Mar 03, 2025 | 2024 (Q4) | -0.500.05 | -0.77 | 106.49% (+0.82) | |
| Nov 06, 2024 | 2024 (Q3) | 0.101.37 | -0.54 | 353.70% (+1.91) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
